Dr Bryce Vissel
Senior Research Fellow; Group Leader, Neuroscience Research Program, Garvan Institute of Medical Research
Email: b.vissel 'at' garvan.org.au
Research Group: Neurodegenerative Disorders
Education
1991 PhD, University of Melbourne
1984 B Pharm (Hons 1), Sydney University
Awards
2002 NSW BioFirst Award
2000 Hereditary Disease Foundation Lieberman Award
1998 Salk Institute Bundy Award
1995 Human Frontiers Research Fellowship
1994 Fulbright Award
1994 CJ Martin Fellowship for Medical Research
1984 WJ Collett Shopee Prize, Pharmaceutical Chemistry
Publications
Kaspar BK, Vissel B, Bengoechea T, Crone S, Randolph-Moore L, Muller R, Brandon EP, Schaffer D, Verma IM, Lee KF, Heinemann SF, Gage FH. Adeno-associated virus effectively mediates conditional gene modification in the brain. Proc Natl Acad Sci U S A 2002; 99(4):2320-5.
Vissel B, Krupp JJ, Heinemann SF, Westbrook GL. Intracellular domains of NR2 alter calcium-dependent inactivation of N-methyl-D-aspartate receptors. Mol Pharmacol 2002; 61(3):595-605.
Vissel B, Krupp JJ, Heinemann SF, Westbrook GL. A use-dependent tyrosine dephosphorylation of NMDA receptors is independent of ion flux. Nat Neurosci 2001; 4(6):587-96.
Vissel B, Royle GA, Christie BR, Schiffer HH, Ghetti A, Tritto T, Perez-Otano I, Radcliffe RA, Seamans J, Sejnowski T, Wehner JM, Collins AC, O'Gorman S, Heinemann SF. The role of RNA editing of kainate receptors in synaptic plasticity and seizures. Neuron 2001; 29(1):217-27.
